123 related articles for article (PubMed ID: 6320579)
21. [Correlation of human papilloma virus (HPV) and herpes simplex virus-2 (HSV-2)in the viral etiology of carcinoma of uterine cervix].
Meng XJ
Zhonghua Zhong Liu Za Zhi; 1989 Mar; 11(2):108-10. PubMed ID: 2553361
[TBL] [Abstract][Full Text] [Related]
22. [Immunoperoxidase demonstration of papillomavirus antigen in dysplasia of the uterine cervix].
Toki T; Oikawa N; Tase T; Wada Y; Yajima A; Suzuki M; Higashiiwai H
Nihon Sanka Fujinka Gakkai Zasshi; 1985 Mar; 37(3):411-5. PubMed ID: 2984298
[TBL] [Abstract][Full Text] [Related]
23. Neutralizing antibodies to herpesvirus types 1 and 2 in carcinoma of the cervix, carcinoma in situ and cervical dysplasia.
McDonald AD; Williams MC; Manfreda J; West R
Am J Epidemiol; 1974 Aug; 100(2):130-5. PubMed ID: 4368955
[No Abstract] [Full Text] [Related]
24. Further studies on an immunoenzymatic assay for herpes simplex virus tumor-associated antigen.
Tarro G; Flaminio G; Maturo S; Esposito C; Cocchiara R
Clin Immunol Immunopathol; 1982 Oct; 25(1):126-32. PubMed ID: 6295672
[No Abstract] [Full Text] [Related]
25. Antibodies to Herpes simplex virus types 1 and 2 in patients with squamous-cell carcinoma of uterine cervix in India.
Seth P; Prakash SS; Ghosh D
Int J Cancer; 1978 Dec; 22(6):708-14. PubMed ID: 214407
[TBL] [Abstract][Full Text] [Related]
26. Persistence and expression of the herpes simplex virus type 2 genome in cervical tumor cells.
Aurelian L
Cancer Res; 1974 May; 34(5):1126-35. PubMed ID: 4367156
[No Abstract] [Full Text] [Related]
27. Persistence and expression of the herpes simplex virus type 2 genome in cervical tumor cells.
Aurelian L
Clin Orthop Relat Res; 1974; (99):78-85. PubMed ID: 4363067
[No Abstract] [Full Text] [Related]
28. A herpesvirus antigen in human premalignant and malignant cervical biopsies and explants.
Cabral GA; Fry D; Marciano-Cabral F; Lumpkin C; Mercer L; Goplerud D
Am J Obstet Gynecol; 1983 Jan; 145(1):79-86. PubMed ID: 6295165
[TBL] [Abstract][Full Text] [Related]
29. Class-specific herpes simplex virus antibodies in sera and cervical secretions from patients with cervical neoplasia: a multi-group comparison.
Dale GE; Coleman RM; Best JM; Benetato BB; Drew NC; Chinn S; Papacosta AO; Nahmias AJ
Epidemiol Infect; 1988 Jun; 100(3):445-65. PubMed ID: 2837405
[TBL] [Abstract][Full Text] [Related]
30. Herpes simplex virus-specific antigens in exfoliated cervical cells from women with and without cervical anaplasia.
Pacsa AS; Kummerländer L; Pejtsik B; Krommer K; Pali K
Cancer Res; 1976 Jul; 36(7 PT 1):2130-2. PubMed ID: 179696
[TBL] [Abstract][Full Text] [Related]
31. Expression of herpesvirus-induced antigens in human cervical cancer.
Dreesman GR; Burek J; Adam E; Kaufman RH; Melnick JL; Powell KL; Purifoy DJ
Nature; 1980 Feb; 283(5747):591-3. PubMed ID: 6243743
[No Abstract] [Full Text] [Related]
32. Complement-dependent cytotoxic antibodies in the course of cervical carcinoma.
Christenson B
Int J Cancer; 1977 Nov; 20(5):694-701. PubMed ID: 200570
[TBL] [Abstract][Full Text] [Related]
33. Neutralization, immunofluorescence and complement fixation tests in identification of antibody to a herpesvirus type 2-induced, tumor-specific antigen in sera from squamous cervical carcinoma.
Aurelian L; Strandberg JD; Marcus RL
Prog Exp Tumor Res; 1974; 19():165-81. PubMed ID: 4612606
[No Abstract] [Full Text] [Related]
34. Possible role of Herpesvirus hominis, type 2, in human cervical cancer.
Aurelian L
Fed Proc; 1972; 31(6):1651-9. PubMed ID: 4351374
[No Abstract] [Full Text] [Related]
35. Viruses and gynecologic cancers: herpesvirus protein (ICP 10/AG-4), a cervical tumor antigen that fulfills the criteria for a marker of carcinogenicity.
Aurelian L; Kessler II; Rosenshein NB; Barbour G
Cancer; 1981 Jul; 48(2 Suppl):455-71. PubMed ID: 7023662
[TBL] [Abstract][Full Text] [Related]
36. Association of Herpes simplex virus (HSV) with cervical cancer by lymphocyte reactivity with HSV-1 and HSV-2 antigens.
Smith JW; Torres JE; Holmquist ND
Am J Epidemiol; 1979 Aug; 110(2):141-7. PubMed ID: 223438
[TBL] [Abstract][Full Text] [Related]
37. Infection with herpes-simplex viruses 1 and 2. II.
Nahmias AJ; Roizman B
N Engl J Med; 1973 Oct; 289(14):719-25. PubMed ID: 4353782
[TBL] [Abstract][Full Text] [Related]
38. Immunocytological demonstration of HSV-II antigen on exfoliated cells from precancerous and cancerous lesions of the uterine cervix.
Gupta MM; Sharma BK; Singh V; Luthra UK
Diagn Cytopathol; 1988 Mar; 4(1):48-9. PubMed ID: 2837373
[TBL] [Abstract][Full Text] [Related]
39. A geographical study of antibodies to membrane antigens of HSV-2-infected cells and HSV-2-specific antibodies in patients with cervical cancer.
Mendis LN; Best JM; Senarath L; Chiphangwi J; Vestergaard BF; Banatvala JE
Int J Cancer; 1981 Nov; 28(5):535-42. PubMed ID: 6273337
[TBL] [Abstract][Full Text] [Related]
40. [Correlation of HSV-2-induced early antigen with antibodies from cervical carcinoma patients].
Jiang JW
Zhonghua Fu Chan Ke Za Zhi; 1986 Mar; 21(2):107-9, 126. PubMed ID: 3017644
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
